SynBioBeta Speaker
Rimma Boshernitsan
CEO, Futurist, Strategist
DIALOGUE
May 2026, SynBioBeta
Speaker
Rimma Boshernitsan is a futurist, strategist, and the founder and CEO of DIALOGUE, an interdisciplinary strategic advisory that helps leaders stop reacting to the zeitgeist—and start shaping it. Over the course of a 20-year career, she has served as a strategic advisor and thought partner to CEOs of emerging businesses and Fortune 500 organizations, including Apple, Tata, Roche, Google, Kaiser Permanente, Aesop, Levi’s, Lyft, Kraft Foods, and Chevron. She has worked internationally, including in Moscow, London, and throughout the U.S.Rimma began her career at Deloitte Consulting’s Human Capital practice, where she focused on M&A and large-scale transformation, before moving into in-house advisory work across healthcare, consumer business, and telecommunications. A period advising contemporary art collectors sharpened her sensitivity to how cultural, political, and scientific shifts often emerge at the edges of institutions before becoming strategic imperatives within them. That insight led her to found DIALOGUE.At the center of Rimma’s work is a model she calls the Triad of Intelligences: human intelligence, machine intelligence, and planetary intelligence. Her work on co-intelligence is not in biotech itself, but adjacent and highly relevant to it—focused on how societies, institutions, and leaders make wiser decisions about health, healthspan, longevity, and the conditions that allow life to flourish. She explores how human intuition, ethical judgment, and living systems awareness must evolve alongside technical capability if innovation is to remain coherent, evidence-based, and humane. In her recent work, including her Noema essay and talks on a planetary nervous system, she argues that health is not only a clinical question, but a systems question.  Rimma’s expertise moves across strategic foresight, AI transformation, and co-intelligent leadership. She has spoken and moderated at SXSW, the Swiss Consulate, WRLDCTY, and other public forums, and is known for guiding conversations that connect frontier innovation to its broader human, ethical, and societal implications. At SynBioBeta, she brings an interdisciplinary lens to the frontier of longevity science—focused less on the lab itself than on the larger questions of judgment, coherence, healthspan, and human consequence that emerge around it.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
Join for the latest
SynBioBeta event updates.